ADUS | Ticker Profile - Titan Protect

ADUS

Addus HomeCare Corporation

Healthcare · Medical Care Facilities · NMS

$92.10

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$1.8B

Total market value of the company

Trailing P/E

17.35

Reasonably valued

Forward P/E

12.58

Based on estimated future earnings — lower means cheaper

Rev Growth

+7.7%

Year-over-year revenue change

Profit Margin

6.9%

How much profit the company keeps from each dollar of revenue

ROE

9.4%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$135.00

+47% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 13 analysts covering this stock

About Addus HomeCare Corporation

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. Its Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company serves federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.

https://www.addus.com

Country: United States Employees: 5,982 Industry: Medical Care Facilities

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

DISTRIBUTION

Smart money appears to be selling into strength — caution

Sharpe Ratio

-0.139

Returns do not compensate for the risk — negative edge

Kelly Fraction

-0.0178

No positive edge detected — the data suggests staying out

Calmar Ratio

-0.243

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-8.2%

Historical annualised return based on price data

Max Drawdown

-33.9%

Largest peak-to-trough decline — the worst it has been

HMM State

BEAR

Statistical model detects bearish conditions

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.92

Less volatile than the market — more defensive

52W High

$124.44

26% below the year high

52W Low

$89.76

3% above the year low

Avg Volume

249,849

Average daily shares traded — higher means easier to buy and sell

Short Ratio

3.2

Days it would take all short sellers to cover — higher means more crowded

Short % Float

5.9%

Moderate short interest

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$5.42

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

12.43

Heavy leverage — higher financial risk if revenues decline

Current Ratio

1.83

Healthy liquidity position

Quick Ratio

1.68

Like current ratio but excludes inventory — stricter test

Gross Margin

32.5%

Revenue left after cost of goods — higher means pricing power

Operating Margin

9.4%

Profit from core operations before interest and tax

Free Cash Flow

$103M

Positive — the business generates more cash than it spends

Revenue (TTM)

$1.4B

Total revenue over the last 12 months

Net Income

$100M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$155.00

Target Median

$135.00

Target Low

$92.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go